The effects of substance P, a putative central and peripheral neurotransmitter, on coronary vasculature and its mechanisms were studied in 31 anesthetized open chest dogs. Without coronary stenosis, intracoronary infusion of substance P (0.001 to 1 pmoIlkg per min) for 40 s increased coronary blood flow up to 173 ± 10.7% in dose-dependent fashion. Application of coronary stenosis created by an inflated intraluminal microballoon that preserved active vasomotion of the stenosed segment produced a pressure gradient of 34 ± 2 mm Hg, a decrease in rest coronary blood flow of 21 ± 1.6% and significant depression of the rate of rise in left ventricular pressure (dP/dt). During coronary stenosis, substance P increased coronary blood flow up to 150 ± 9.4%, lowered mean distal coronary pressure and decreased stenosis resistance in dosedependent fashion.
ished. In vitro measurements of isometric tension from both intact and denuded portions of coronary arteries confirmed a marked inhibition of substance P·induced relaxation in the denuded segments. These results show the obligatory role of the endothelium in substance P·induced coronary artery dilation. Furthermore, intracoronary infusion of substance P (1 pmoIlkg per min) from the site distal to coronary stenosis that precluded the responsiveness of the large coronary artery decreased coronary blood flow by 24 ± 4%, lowered mean distal coronary pressure by 15 ± 1.9 mm Hg and intensified stenosis resistance by 77 ± 7.2%.
Thus, substance P exerts a direct potent dilating effect on both large and small coronary arteries. However, because of its strict endothelium-dependency, this peptide may play a detrimental role in the regulation of coronary blood flow when an atherosclerotic stenotic lesion with endothelial damage or dysfunction is present in the proximal part of the coronary artery.
(J Am Coil CardioI1990; 15:1374-84) thought to partIcIpate in cardiovascular reflexes and the transmission of cardiac pain (6) . Systemic infusion of this peptide in animals produced a rapid decrease in blood pressure and associated tachycardia (10) . Local infusion of the peptide in human forearm vasculature revealed that it was a potent arteriolar vasodilator (11, 12) . Brum et al. (8) found significant concentrations of substance P-like immunoreactivity in canine epicardial coronary arteries, and proposed that it might directly affect coronary vascular tone after its release from peripheral sensory nerve endings. The peptide exerts potent endothelium-dependent dilatory responses in studies using isolated arterial preparations (13) and intact canine femoral arteries (14) . These observations have raised the question as to the possible roles of this peptide and the influences of coronary stenosis on regulating coronary blood flow in an intact animal. Although some investigations described the effects of this peptide on coronary circulation in the isolated (15) and intact (16) dog heart, none of these studies were per-formed under the condition of coronary stenosis or endothelial dysfunction, or both, resembling human atherosclerotic coronary lesions.
We have developed an experimental model of dynamic coronary stenosis that preserves active vasomotion of the stenosed segment, resembling human atherosclerotic coronary lesions that contain some intact smooth muscles and maintain stenosis vasomobility (17, 18) . This model has been proved to be appropriate in investigating the effects of vasoconstricting and vasodilating agents (19) (20) (21) (22) and the changes in myocardial metabolic demand (23) on the coronary vasculature and the therapeutic mechanisms of cardiovascular drugs (20, 24, 25) . In the present study, we evaluated the quantitative dose-response relations of substance P to coronary vasculature in an experimental model of coronary stenosis and clarified the mechanisms involved in the observed effects.
Methods
Experimental preparation. This project conformed to the "Position of the American Heart Association on Research Animal Use" adopted by the American Heart Association.
Thirty-one mongrel dogs of either gender. weighing II to 18 kg, were pretreated with subcutaneous morphine (I mg/kg body weight), anesthetized with intravenous alphachloralose (100 mg/kg) and ventilated by a mechanical respirator with intermittent positive pressure, using room air supplemented with oxygen. Blood gases and acid-base balance were maintained within normal limits (26) . A catheter was passed through the right femoral artery and advanced into the aortic arch for aortic pressure monitoring. Another catheter was also placed in the femoral vein for intravenous infusion. A left thoracotomy was performed at the fifth intercostal space, and the heart was suspended in a pericardial cradle. In six dogs, a polyethylene tubing (0.6 mm outer diameter) was advanced retrogradely through a small branch of the circumflex coronary artery distal to the proposed occlusion site until its tip was just distal to the stenosis for distal coronary infusion of substance P. In the second distal branch. another polyethylene catheter was placed to record distal coronary pressure. A stiff catheter. 10 cm long, was inserted into the left ventricle through the apex to record left ventricular pressure and rate of rise of pressure (dP/dO. The left common carotid artery was exposed, and a segment approximately 1 cm long, of the left circumflex coronary artery was dissected free. After administration of 5,000 U of heparin, the circumflex coronary artery was ligated, promptly cannulated just at its distal portion with a thin metal cannula (2.4 mm inner diameter) and perfused continuously from the carotid artery through bypass perfusion tubing with a minimal internal diameter of 2.4 mm (Fig. I) . Heparin (2,000 U) was supplemented every 30 min.
Coronary perfusion pressure at the tip of the cannula was measured, and it was confirmed that mean coronary perfusion and aortic pressures were nearly identical in each experiment. In addition, the adequacy of this perfusion system was confirmed by preserved autoregulatory reserve (peak reactive hyperemic response was>300% of basal flow after a 15 s total coronary artery occlusion) in each dog. Circumflex coronary blood flow was measured using an extracorporeal electromagnetic flow probe (Nihon Kohden FF-030T, inner diameter 3 mm). Pressures were measured with a Statham P23Db transducer. Heart rate, aortic pressure. mean distal coronary pressure and coronary blood flow were continuously monitored. Each preparation was allowed to stabilize for at least 30 min after coronary cannulation. Production of dynamic coronary stenosis. The concept and characteristics of dynamic coronary stenosis have been described previously (19) (20) (21) (22) (23) (24) (25) . Briefly, dynamic coronary stenosis was produced by inflating a specially made microballoon occluder, consisting of a minute rubber balloon attached to the tip of the polyethylene tubing. This occluder was inserted through the side arm of the perfusion tubing and advanced into the intact proximal portion of the circumflex coronary artery. There was no major branch between the cannula and the occluder. It was confirmed that the placement of the occluder into the coronary artery did not affect coronary blood flow at rest, its phasic pattern or the peak reactive hyperemic response before its operation. The size of the balloon was finely adjusted by expansion with saline solution to obtain a pressure gradient across the stenosis of approximately 30 mm Hg, and the expansion volume was kept constant. The severity of the stenosis was evaluated by the mean pressure gradient across the stenosis; stenosis resistance was calculated by dividing the mean coronary pressure gradient across the stenosis (that is, subtracting mean distal coronary pressure from mean aortic pressure) by mean coronary blood flow.
Effects of intracoronary substance P administration. Dose-response relations of intracoronary infusion of substance P (0.001, 0.01, 0.1 and 1 pmol/kg per min) were examined in 16 dogs. The dogs were classified into two subgroups: eight dogs without and eight dogs with coronary stenosis. In the latter group, coronary stenosis was produced after recordings under rest conditions. The peptide was dissolved in a saline solution containing 0.1 % bovine serum albumin, diluted in an appropriate concentration and infused through the bypass tubing into the circumflex coronary artery (proximal infusion) for 40 s at a rate of 0.2 ml/min. The response to the peptide was always apparent within this time period. Because the hemodynamic changes in response to this peptide were relatively transient, maximal responses of each hemodynamic variable were observed in each perturbation. In the preliminary study, it was confirmed that this perfusion rate of substance P vehicle did not affect coronary hemodynamic variables and that the transit time between injection site and cannula tip was less than a few seconds in the presence and absence of coronary stenosis. The sequence of varying doses of the peptide was selected randomly. Under each condition, at least 20 min were interposed between each perturbation to confirm the full recovery of all hemodynamic variables to the control state and exclude the possible development of tachyphylaxis.
Effects of endothelial denudation in vivo. To examine the role of the endothelium in response to intracoronary substance P administration, endothelial denudation was performed around the site where the microballoon occluder was placed in eight dogs. After the effects of substance P (0.1 and 1 pmol/kg per min) infusion for 40 s were examined without and with coronary stenosis as control studies, endothelial denudation was performed. A 2F Fogarty embolectomy catheter (American Edwards Laboratories) was inserted through the side arm of the perfusion tubing and placed in the proximal portion of the circumflex artery. The intima of this portion was mechanically deendothelialized by balloon inflation and drawing of the catheter. The balloon size of the embolectomy catheter was previously adjusted so as not to distend the artery. The microballoon occluder was then placed in the portion of the artery where mechanical rubbing had been applied. The effects of intracoronary substance P (0.1 and 1 pmol/kg per min) were again examined in the absence and presence of partial coronary obstruction. To exclude the possibility that endothelial damage might alter the responsiveness of the vascular smooth muscle, the responses to a 40 s infusion of nitroglycerin (1 p,g/kg per min) were also compared before and after the procedure.
Organ chamber experiment on coronary artery segments. At the end of the denudation experiment in vivo, coronary arteries from six dogs were immediately isolated and cleaned of surrounding tissue. Helical strips approximately 2 mm wide and 20 mm long were obtained from both the endothelium-denuded portion of the circumflex coronary artery and the intact proximal portion of the left anterior descending artery. For recording isometric tension, strips were suspended in 30 ml organ baths containing buffer of the following composition (mM): sodium chloride, 118; potassium chloride, 4.0; calcium chloride, 1.5; magnesium sulfate, 1.2; sodium phosphate, monobasic, 1.2; sodium bicarbonate, 25; and glucose, 5 (27) , and equilibrated at 37°C with a 95% oxygen-5% carbon dioxide gas mixture. Final pH was approximately 7.38. An initial preload of 1.5 g was applied to each strip. The equilibration time before the relaxation experiment was 1.5 to 2 h. The tension of the coronary artery at rest was approximately I g. A test contraction was induced by adding 20 mM of potassium chloride. When developed tension attained its peak value, the strips were relaxed by rinsing with the buffer. They were then precontracted by 2 pM of prostaglandin F 2u and subsequently relaxed by the cumulative addition of substance P (l pmol to 100 nmol). Dose-response relations were determined for each portion of coronary artery segments.
Histologic examination. To assess the morphologic characteristics of the denudation site, the vascular samples from the intact and denuded coronary arteries were fixed in a 10% formaldehyde solution. The specimens were stained with hematoxylin-eosin and examined microscopically.
In some dogs. vital staining was performed to confirm the vascular area of denudation. Evans blue dye (400 mg dissolved in 20 ml of isotonic sodium chloride solution) was intravenously administered at the end of the experiment. Thirty minutes later, the dog was killed and the heart was promptly resected. The coronary tree was flushed with the buffer, and the circumflex coronary artery was opened longitudinally and inspected for blue staining, which signified endothelial trauma (28) .
Effects of distal substance P infusion. In six dogs, the effects of distal coronary infusion of substance P were compared with those of proximal infusion through the perfusion circuit in both stenosis-absent and stenosis-present conditions. All hemodynamic measurements were made continuously during rest conditions, coronary stenosis, drug infusion and for 5 min after cessation of the infusion.
Materials. Synthetic substance P (Sigma Chemical Co.) was dissolved in normal saline solution containing 0.1% bovine serum albumin to give a dose of 0.1 mg/ml, and stored at -80°C before use. Nitroglycerin (Millisrol, Nihonkayaku Co., Tokyo, Japan) was dissolved in distilled water; prostaglandin F 2u was obtained from Sigma Chemical Co. Each agent was prepared in an appropriate dose each time before use. Statistical analysis. The results of in vivo experiments were expressed as mean values ± SEM. Data for a single response in the same dog were analyzed by Student's t test for paired comparison. Differences among the different doses of each group were analyzed by analysis of variance and Tukey's test. In in vitro experiments, the responses to the peptide were expressed as mean values ± SEM percent relaxation of the prostaglandin F 2u -induced contraction, and the significance of the difference between group means was assessed with Student's t test for 
Results
Effects of intracoronary substance P administration. Systemic and coronary hemodynamic variables in dogs without and with coronary stenosis are shown in Tables 1 to 3 . Without coronary stenosis. intracoronary administration of substance P (0.001 to 1 pmol/kg per min) significantly increased coronary blood flow in a dose-dependent manner. Maximal increases in coronary blood flow were 10 ± 2.5% (p < 0.01). 16 ± 3.8% (p < 0.01). 48 ± 11.4% (p < 0.01) and 73 ± 10.7% (p < 0.01) at the doses of 0.001, 0.01. 0.1, and 1 pmol/kg per min. respectively (Fig. 2) . Systemic hemodynamic variables did not change during the infusion of any doses of substance P ( Table I) . Each dose of the peptide produced transient but significant increases in coronary blood flow that were observed several seconds after the start of the infusion and began to decline during the infusion period. The coronary effects of repeated administration of any dose of substance P were confirmed to be reproducible at 20 min intervals.
Application of coronary stenosis ( Table 2) , produced a mean pressure gradient of 34 ± 2 mm Hg (p < 0.01) and a decrease in coronary blood flow of 21 ± 1.6% (p < 0.01). Left ventricular dP/dt decreased by 127 ± 21 mm Hg/s (p < 0.01). During coronary stenosis. the dose-dependent increases in coronary blood flow and decreases in mean distal coronary pressure in response to intracoronary substance P infusion were significant at doses >0.1 pmol/kg per min (Fig.  2) . Maximal increases in coronary blood flow were 8 ± 4.7% (p = NS), 10 ± 5.3% (p = NS). 31 ± 7.2% (p < 0.01) and 50 ± 9.4% (p <0.01) for each incremental dose between 0.001 and 1pmol/kg per min. and maximal decreases in mean distal coronary pressure were 5 ± 1.8 (p < 0.05) and 7 ± 2.2 mm Hg (p < 0.01) for the doses of 0.1 and 1pmol/kg per min ( 3). Stenosis resistance decreased significantly by administration of the two higher doses; however, changes in left ventricular dP/dt did not reach statistical significance. Effects of endothelial denudation in vivo (Table 4 ). There were no significant differences in basal systemic and coronary variables before and 15 min after endothelial removal. Coronary blood flow increment in response to intracoronary Figure 3 . Effects of intracoronary (i.e.) substance P (SP) (I pmol/kg per min). A. without coronary stenosis, it can be seen that substance P increased coronary blood flow without any changes in systemic hemodynamic variables. B, With coronary stenosis, substance P increased coronary blood flow, with a concomitant decrease in distal coronary pressure. However, no significant changes in left ventricular (LV) end-diastolic pressure or rate of rise of pressure (dP/dt) were seen during the experimental period. Values are mean values ± SEM. Abbreviations as in Tables I and 3. substance P infusion without coronary stenosis (Fig. 4, right (Fig. 5A) .
Intracoronary infusion of nitroglycerin (1 J.Lg/kg per min)
was performed in seven dogs with coronary stenosis before and after endothelial denudation. There was no significant difference in preinjection values of systemic and coronary hemodynamic variables before and after the procedure. Nitroglycerin significantly increased coronary blood flow and mean distal coronary pressure and decreased stenosis resistance after endothelial denudation to the same extent as before the procedure (coronary blood flow increment: before, 35 ± 11.0%; after, 28 ± 16.0%; mean distal coronary pressure increment: before, 13 ± 3.7 mm Hg; after, 8 ± 1.5 mm Hg; stenosis resistance decrement: before, 48 ± 3.7%; after, 37 ± 6.7%) (Fig. 5B) . No significant systemic hemodynamic changes were seen with intracoronary nitroglycerin infusion before and after the procedure.
Organ chamber experiment on coronary segments. Figure  6 shows the effects of substance P on vascular tones of isolated coronary arteries obtained from both intact and denuded portions of the endothelium. Dose-response curves for substance P-elicited changes in isometric tension during precontraction by prostaglandin F 2a were compared. Substance P (0.1 to 100 nmol) induced dose-dependent relaxation in endothelium-intact arteries. Almost maximal relaxation was achieved by application of 10 nmol of the peptide (67 ± 9.0%). However, substance P-induced relaxation of the endothelium-denuded arteries was almost completely abolished (7 ± 3.7% by 10 nmol). Histologic examination. Light microscopic study revealed the presence of an endothelial lining in intact coronary artery segments (Fig. 7A) . Denuded segments showed the absence of endothelial cells, with a few adherent platelets attached to the luminal side and preserved internal elastic lamina and media (Fig. 7B) . In addition, the denuded area in the circumflex artery in which the vital staining was performed was clearly tinted blue by Evans blue dye. The blue-stained area was approximately 2 cm in length and was present in the entire circumference.
Effects of distal coronary infusion of substance P. Without coronary stenosis, increases in coronary blood flow induced by substance P were similar between the proximal and distal coronary infusions. The percent increments in coronary blood flow in response to substance P infusion were 34 ± 6.9% and 27 ± 6.7% (p = NS) at 0.1 pmol/kg per min and 74 ± 16.9% and 70 ± 15.1% (p = NS) at I pmol/kg per min, respectively. With coronary stenosis, distal infusion of substance P at 0.1 pmol/kg per min did not increase coronary blood flow significantly in contrast with proximal infusion (23 ± 4.4% and 3 ± 4.8% for proximal and distal infusion, respectively), and distal infusion of the peptide at its highest dose exhibited a substantial decrease in coronary blood flow (50 ± 12.8% increase and 24 ± 4.0% decrease for proximal and distal infusion, respectively, p < 0.05). This decrement in coronary blood flow was accompanied by an accentuated decrease in mean distal coronary pressure (8 ± 1.2 versus IS ± 1.9 mm Hg) and an intensification of stenosis resistance Figure 7 . Photomicrographs of sections of canine coronary arteries before and after endothelial denudation. A, Transverse section of the control coronary artery with an intact endothelial cell layer. B, Transverse section of the denuded segment of coronary artery showing an absent endothelial layer with normal internal elastic lamina and media with a few adherent platelets (hematoxylin-eosin stain; original magnification x100, reduced by 29%).
(20 ± 6.6% decrease versus 77 ± 7.2% increase, p < 0.01) (Fig. 8) .
Discussion
This study demonstrates that substance P, an amino acid peptide, is a potent dilator in both large and small coronary arteries and that this peptide produces a beneficial effect on coronary vasculature during dynamic coronary stenosis. The dilating action of this peptide on epicardial coronary arteries is present only in the presence of intact endothelium in vivo and in vitro.
Effects of substance P without coronary stenosis. In intact coronary circulation, intracoronary infusion of substance P produced dose-dependent increases in coronary blood flow without changing systemic hemodynamic variables, indicating that it has a direct vasodilatory action on the small coronary artery. Whether this peptide has a direct action on SUBSTANCE P·INDUCED CORONARY VASODILATION lACC Vol. 15. No. 6 May 1990: 1374-84 Figure 8 . Effects of distal substance P (SP) infusion on coronary hemodynamic variables during coronary stenosis as compared with proximal substance P infusion (control). Distal infusion of the highest dose of substance P elicited a decrease in coronary blood flow (CBF), an augmented decline in mean distal coronary pressure (DCP) and an intensification of stenosis resistance (SR). The data are expressed as mean ± standard error of the mean during preinjection (P) and infusion (I) periods. Compared with preinjection: *p < 0.05, **p < 0.01, respectively; compared with corresponding values in control: tp < 0.05, ttp < 0.01. respectively.
usually complete within 10 min and readily disappears after the washout. Perhaps such shortness of biologic activity would account for insignificant changes in left ventricular dP/dt during the coronary flow increment elicited by the peptide. In this experiment, tachyphylaxis was avoided because the repeated infusion of the same dose of the peptide after a 20 min interval caused similar hemodynamic responses, which is in accordance with previous human observations (31) . Effects of substance P with coronary stenosis. The effects of substance P were evaluated under the condition of flowlimiting coronary stenosis. In this situation, the autoregulatory reserve is almost exhausted in the subendocardium, whereas some reserve is still present in the subepicardium (20) (although regional blood flow was not measured in this study). Intracoronary infusion of substance P during coronary stenosis increased coronary blood flow together with a decrease in mean distal coronary pressure and stenosis resistance. This can be explained by the preferential dilation of the large coronary artery and the concomitant dilation of the small coronary artery. Both endothelial denudation and distal infusion experiments were performed to further clarify the role of this peptide in regulating large coronary artery tone.
After endothelial denudation of the proximal coronary artely. the coronary blood flow increment in response to intracoronary substance P infusion without coronary stenosis was not significantly altered, showing that the dilating capacity of the small coronary artery was well preserved by this intervention. Careful attention was paid to establishing an inflation volume of the balloon catheter to produce only endothelial denudation without discernible overdistension of the artery wall and smooth muscle damage. The adequacy of this procedure was confirmed by the response to nitroglycerin, a direct vascular smooth muscle dilator, and histologic studies and the organ chamber experiment on coronary segments. Beneficial effects of nitroglycerin during coronary stenosis were a result of selective dilating action of the large coronary artery (24) , and this response was similar before and after endothelial denudation. In contrast, the coronary blood flow increment in response to the peptide during coronary stenosis was almost completely abolished after endothelial denudation. These results suggest that vasodilator activity of substance P depends on endothelial integrity.
Distal coronary infusion of substance P increased coronary blood flow to the same extent as proximal infusion without coronary obstruction, indicating almost the same dilatory responsiveness of the small coronary artery. In contrast, the deleterious response of the coronary vasculature to the highest dose of this peptide during coronary stenosis can be explained by the mechanism of passive narrowing of the stenosed segment. Briefly, potent dilation of the small coronary artery in response to this peptide causes a decrease in intraluminal-distending pressure distal . .
..
a:
the heart is controversial, although the localization of substance P-like immunoreactive nerves in the atrium and within the ventricular myocardium is well observed (3, 4) . Relatively high doses of the peptide, which caused systemic hypotension, reflex tachycardia and associated increase in cardiac output, were used in studies (16, (29) (30) (31) favoring positive cardiotropic action of this peptide. At a concentration as low as that used in other studies (15, (32) (33) (34) and in ours, this peptide may not exert a cardiotropic action. An increase in coronary blood flow in response to substance P infusion was rapid, transient and began to disappear within a minute, even during continued infusion. This result is in accordance with that in other studies (11, 30) in which the peptide was infused systemically in dogs and in humans and showed a rapid achievement of its maximal effect. McEwan et al. (12) demonstrated that the biologic half-time of substance P in a human forearm blood vessel is about 15 s. Desensitization to the peptide is also demonstrated (13) in isolated arterial preparations of various species, which is to the stenosis and results in a paradoxic intensification of stenosis severity (35, 36) . The result also minimizes any role of flow-dependent dilation of the large coronary artery (37) in the increase in coronary blood flow during coronary stenosis because the mechanism of passive narrowing easily outstripped the flow-dependent dilator effect during coronary stenosis. In addition, the possibility of "coronary steal" and diversion of myocardial blood flow from subendocardium to subepicardium should also be considered in this situation (38) .
Role of endothelial denudation. If the endothelial denudation procedure nullifies the epicardial arterial vasodilator response, this intervention would, theoretically, produce the same effect on coronary vasculature as that of distal infusion experiments. However, the increment in coronary blood flow during coronary stenosis after the denudation was not perfectly inhibited. The reason for this small increase in coronary blood flow may be explained by incomplete deendothelialization in situ or release of a relaxing factor from the intact endothelial cells adjacent to the damaged site, which was completely precluded by the distal coronary infusion of this peptide. The contribution of released prostacyclin on endothelium-mediated vasorelaxation could be neglected because relaxation by substance P is not influenced by cyclooxygenase inhibitors (39) .
Thus, the responses to proximal infusion of the higher doses of substance P during coronary stenosis can be explained by its opposing effects on coronary vasculature (namely, a reduction in stenosis severity due to active dilation of the intact large coronary artery and a passive narrowing of the stenosed segment caused by small coronary artery dilation). Net effects of the two mechanisms are manifest in the proximal infusion experiment, but the former effect is completely precluded in the distal coronary infusion experiment and is markedly attenuated in the denudation experiment.
Clinical implications. It has been suggested (40) that endothelial damage can playa role in the pathophysiology of coronary vasospasm. Furthermore, the relation between atherosclerosis and vasospasm raises the possibility that atherosclerosis-induced endothelial damage would alter vasoactive responsiveness to neurohumoral and pharmacologic stimuli. Impairment of the endothelium-dependent relaxation in response to agents such as acetylcholine, substance P and bradykinin has been noted in atherosclerotic arteries of human and animals (39, 41, 42) . This lack of vasodilating ability in atherosclerotic arteries appears to be important as the cause of myocardial ischemia. The precise mechanism whereby substance P peptidergic nerves in coronary arteries are activated remains to be elucidated, as well as the extent to which they influence coronary vasodilator tone under normal and pathophysiologic conditions in humans.
Conclusions. We have demonstrated that substance Pinduced dilation of the canine epicardial coronary artery is endothelium-dependent in vivo and in vitro. Substance P can induce a direct potent dilating effect on the large and small coronary arteries and exhibits a beneficial effect in restoring coronary blood flow during coronary stenosis. However. in view of its strict endothelium dependence, this peptide could playa detrimental role in the regulation of myocardial blood flow supplied by an atherosclerotic stenotic artery with endothelial dysfunction or damage.
